TIMESPAN & ART-CARMA
2022
- RADAR BASE (18 Jan 2022) TIMESPAN: ART-CARMA
- KCL ( 17 Jan 2022) ART-CARMA – The ADHD Remote Technology study of cardiometabolic risk factors and medication adherence
- empatica (17 Jan 2022) ART-CARMA study: measuring and improving medication adherence in adults with ADHD using EmbracePlus
TIMESPAN press releases
2021
- SUNY (29 April 2021) Three Upstate researchers participate in international study looking at ADHD and cardiometabolic disease
- KI (20 April 2021) New European Commission Horizon 2020 grant – “TIMESPAN”, KI Newsroom
- UOL (20 April 2021) Improving treatment for ADHD patients with cardiometabolic diseases, University of Iceland
- KCL (12 April 2021) Wearable tech and smartphone apps to be used in new ADHD project, Health Tech Newspaper
- KCL (08 April 2021) ART-CARMA Clinical Study part of 6m Euro global programme, Mirage News
- KCL (08 April 2021) ART-CARMA Clinical Study part of 6m Euro global programme, King’s College London
- UNSW (06 April 2021) Funding drives research into treating people with ADHD and cardiometabolic diseases, UNSW Newsroom
TIMESPAN non-English editions
Online articles in the Estonian press
2022
- UTARTU (23 August 2022) Geenid näitavad kätte ka ajuhaiguste põhjused, Tervis.Postimees
TIMESPAN & EASO Newsletter
2022
2021
